Navigation Links
Looking Towards More Effective Leukemia Treatment

Eighty percent of the time childhood acute lymphoblastic leukemia is curable with chemotherapy. The bad news is doctors are not sure // why it doesn’t work for the other 20 percent of patients. Now, new research finds it could be because of a small number of genes that are resistant to drugs used to treat the disease.

Researchers tested leukemia cells from 173 children. They looked at the sensitivity of the cells to four different treatment drugs. The cells were then assessed to identify which ones were drug-sensitive and which ones were drug-resistant. The gene-expression patterns were then compared with the original 173 patients and 98 children from another institution.

Researchers identified a number of different genes that were resistant to each of the four drugs. They found the patients with more of the resistant genes were less likely to respond to treatment. Researchers say of the 124 genes identified, 121 have not previously been associated with resistance to the four chemotherapy drugs.

Thus researchers conclude saying that a relatively small number of genes can play a role in the resistance to treatment for children with acute lymphoblastic leukemia.
'"/>




Page: 1

Related medicine news :

1. Palmist Claims to Diagnose Ailments Looking At Your Palm
2. Plastic Surgeons Looking Forward To First Full Face Transplant
3. Looking For A Friend Or Life Partner? Join A Gym
4. Researchers Looking for Genes That Control the Brain
5. Attitude Towards AIDS Patients – Time For A Change
6. Scientists Awarded Appropriately For Contribution Towards Medical Research
7. A Step Towards Unraveling The Schizophrenia And Depression Mystery
8. Are Women Not Hearty Enough Towards Seeking Heart Care?
9. RPB grants $7.9 Million Towards Research
10. Blood Transfusion May Have Contributed Towards Hepatitis C
11. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory Consortium ... . The site houses a wealth of federal resources that businesses can leverage ... called technology transfer (T2). As a network of over 300 federal laboratories, the ...
(Date:2/8/2016)... ... February 08, 2016 , ... A man who has struggled to quit smoking, a man ... , was determined to find solutions to his problems – and he did. Now Nabat, ... is ready to introduce his breakthrough inventions to the world and better people's lives. His ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Bell Agency, a full ... beneficiary of their ongoing community enrichment program. The current campaign fundraises for Angels ... are now being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... frequently. While a significant number of women and men with eating disorders report ... itself, that best predicts the development of an eating disorder. , At ...
(Date:2/8/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to a product from ... a cluster of melanin when exposed to sunlight. Although most moles are benign and ... embarrassment. Historically, mole removal has involved a painful, often expensive visit to ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
(Date:2/8/2016)... February 8, 2016 ... published by Allied Market Research titled, "World ... Forecasts, 2014-2020", estimates the world synthetic biology market ... and sequencing technology segment would continue to lead ... tools segment, collectively, held around half of the ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, ... heute eine Infografik mit dem Titel „Epilepsy ... Welt), mit der der Krankheit gegenüber ein ... dazu ermutigen soll, Medikamentenresistenz bei Epilepsie auf ... allgemeinen Diskussion zu machen. Mithilfe der neuen ...
Breaking Medicine Technology: